title: Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
authors.affiliation: Cancer and Leukemia Group B, University of California, San Francisco, CA 94115, USA. venook@cc.ucsf.edu
authors.forename: Alan P
authors.initials: AP
authors.lastname: Venook
authors.forename: Charles D
authors.initials: CD
authors.lastname: Blanke
authors.forename: Donna
authors.initials: D
authors.lastname: Niedzwiecki
authors.forename: Heinz-Josef
authors.initials: HJ
authors.lastname: Lenz
authors.forename: John R
authors.initials: JR
authors.lastname: Taylor
authors.forename: Donna R
authors.initials: DR
authors.lastname: Hollis
authors.forename: Susan
authors.initials: S
authors.lastname: Sutherland
authors.forename: Richard M
authors.initials: RM
authors.lastname: Goldberg
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D001688:Biological Products / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D009367:Neoplasm Staging
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D000068258:Bevacizumab; D000068818:Cetuximab; D002955:Leucovorin; D005472:Fluorouracil